ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $452,000 | -85.8% | 12,150 | -80.5% | 0.01% | -86.4% |
| Q2 2020 | $3,189,000 | +62.7% | 62,150 | 0.0% | 0.04% | +41.9% |
| Q1 2020 | $1,960,000 | -48.6% | 62,150 | 0.0% | 0.03% | -18.4% |
| Q4 2019 | $3,813,000 | +64.7% | 62,150 | -1.6% | 0.04% | +52.0% |
| Q3 2019 | $2,315,000 | -21.2% | 63,135 | 0.0% | 0.02% | -21.9% |
| Q2 2019 | $2,938,000 | +46.3% | 63,135 | +26.3% | 0.03% | +45.5% |
| Q1 2019 | $2,008,000 | – | 50,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |